Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Valproic Acid for Hair Loss
NCT01548066Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of valproic acid in androgenetic alopecia (AGA) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Linear hair growth rate at 24 weeks. Started Sep 2011; status: completed.
02
Drugs
valproic acid
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT01548066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01548066.